Systemic lupus erythematosus. Diagnosis and treatment (Q41333508)

29 September 2017

1 reference

title

Systemic lupus erythematosus. Diagnosis and treatment (English)

1 reference

29 September 2017

St Clair EW

1 reference

29 September 2017

Pisetsky DS

1 reference

29 September 2017

Gilkeson G

series ordinal

1 reference

29 September 2017

publication date

1 January 1997

1 reference

Medical Clinics of North America

29 September 2017

published in

1 reference

29 September 2017

1 reference

29 September 2017

1 reference

29 September 2017

page(s)

113-128

1 reference

The neuropsychiatric manifestations of systemic lupus erythematosus: an overview

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970507-1

Long-term follow-up of patients with lupus nephritis. A study based on the classification of the World Health Organization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970507-1

Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970507-1

Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970507-1

Prognostic factors in lupus nephritis. Contribution of renal histologic data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970507-1

Pathology and pathogenesis of vascular injury in systemic lupus erythematosus. Interactions of inflammatory cells and activated endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970507-1

Effects of immunosuppressive drugs during pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970507-1

Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970507-1

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970507-1

Association between Lupus Psychosis and Antiribosomal P Protein Antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970507-1

Systemic lupus erythematosus: emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970507-1

Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970507-1

Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970507-1

Systemic lupus erythematosus: emerging concepts. Part 2: Dermatologic and joint disease, the antiphospholipid antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality, and pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970507-1

Assessment of disease activity and impending flare in patients with systemic lupus erythematosus. Comparison of the use of complement split products and conventional measurements of complement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970507-1

A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970507-1

Central nervous system involvement in systemic lupus erythematosus: A review of neuropathologic findings in 57 cases, 1955–1977

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970507-1

Renal transplantation in systemic lupus erythematosus: a single-center experience with sixty-four cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970507-1

Antibodies to DNA. A perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970507-1

Focal cerebral ischemia and antiphospholipid antibodies: a case for cardiac embolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970507-1

Antineuronal antibodies in neuropsychiatric systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970507-1

Comparison of mesna with forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplantation: a prospective randomised study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970507-1

The spectrum of neurologic disease associated with antiphospholipid antibodies. Lupus anticoagulants and anticardiolipin antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970507-1

A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970507-1

Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970507-1

Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970507-1

Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970507-1

Thrombosis and antiphospholipid syndrome: a preliminary assessment of three antithrombotic treatments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970507-1

Antiphospholipid Thrombosis: Clinical Course after the First Thrombotic Event in 70 Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970507-1

Single-photon-emission computed tomography analysis of cerebral blood flow in the evaluation of central nervous system involvement in patients with systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970507-1

Irreproducibility of the activity and chronicity indices limits their utility in the management of lupus nephritis. Lupus Nephritis Collaborative Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970507-1

The 1982 revised criteria for the classification of systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970507-1

Causes of death in systemic lupus erythematosus. Long-term followup of an inception cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970507-1

Neuropsychiatric lupus erythematosus: a 10-year prospective study on the value of diagnostic tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970507-1

Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970507-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-7125(05)70507-1

1 reference

release_evn5m5673bf5xpurbekt323e2u

29 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/evn5m5673bf5xpurbekt323e2u

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference